KalVista Pharmaceuticals (KALV) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q3 2025
Q3 2025
Q4 2025
-1.12
-0.97
-0.82
-0.67

Details

Expected EPS
-0.672222
Actual EPS
-0.92
Surprise EPS
-0.25
Surprise Percent
+36.86%

Description

KalVista Pharmaceuticals (KALV) has reported earnings of -0.92 per share for Q4 2025.

0 Comments

Share your thoughts